# Radar Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/radar-therapeutics

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.radartx.bio
- Total disclosed funding: $13M
- Latest round: Seed (May 23, 2024)
- Investors on record: 7

## About

Based in California, US, and founded in 2022 by co-founders Eerik Kaseniit and Sophia Lugo, Radar Therapeutics operates as a provider of precision RNA-based therapies primarily for oncology, using advanced RNA sensing technology.

The company provides gene detection technology for specific cell targeting in cancer treatment.

## Funding rounds

- Seed, May 23, 2024, $13M — Eli Lilly & Company, Pear VC, NFX, KdT Ventures, Biovision Ventures, BEVC
- Seed, Feb 12, 2024 — Pioneer Fund

## Investors

- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed
- Eli Lilly & Company — Seed
- Pear VC (https://capitalatlas.ai/funds/pear-vc) — Seed
- NFX (https://capitalatlas.ai/funds/nfx) — Seed
- KdT Ventures (https://capitalatlas.ai/funds/kdt-ventures) — Seed
- Biovision Ventures (https://capitalatlas.ai/funds/biovision-ventures) — Seed
- BEVC (https://capitalatlas.ai/funds/bevc) — Seed